167 related articles for article (PubMed ID: 31279844)
21. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
22. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
23. Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Hada M; Edin ML; Hartge P; Lih FB; Wentzensen N; Zeldin DC; Trabert B
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):189-197. PubMed ID: 30262599
[TBL] [Abstract][Full Text] [Related]
24. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract][Full Text] [Related]
25. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
26. Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B
Trabert B; Geczik AM; Bauer DC; Buist DSM; Cauley JA; Falk RT; Gierach GL; Hue TF; Lacey JV; LaCroix AZ; Michels KA; Tice JA; Xu X; Brinton LA; Dallal CM
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2030-2037. PubMed ID: 34465588
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.
Kozar N; Kruusmaa K; Dovnik A; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Takač I; Arko D
Adv Med Sci; 2021 Mar; 66(1):46-51. PubMed ID: 33360772
[TBL] [Abstract][Full Text] [Related]
28. Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.
Brinton LA; Trabert B; Anderson GL; Falk RT; Felix AS; Fuhrman BJ; Gass ML; Kuller LH; Pfeiffer RM; Rohan TE; Strickler HD; Xu X; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1081-9. PubMed ID: 27197275
[TBL] [Abstract][Full Text] [Related]
29. The WID-EC test for the detection and risk prediction of endometrial cancer.
Barrett JE; Jones A; Evans I; Herzog C; Reisel D; Olaitan A; Mould T; MacDonald N; Doufekas K; Newton C; Crosbie EJ; Bjørge L; Colombo N; Dostalek L; Costas L; Peremiquel-Trillas P; Ponce J; Matias-Guiu X; Zikan M; Cibula D; Wang J; Sundström K; Dillner J; Widschwendter M
Int J Cancer; 2023 May; 152(9):1977-1988. PubMed ID: 36533702
[TBL] [Abstract][Full Text] [Related]
30. A case control study of sarcosine as an early prostate cancer detection biomarker.
Ankerst DP; Liss M; Zapata D; Hoefler J; Thompson IM; Leach RJ
BMC Urol; 2015 Oct; 15():99. PubMed ID: 26429735
[TBL] [Abstract][Full Text] [Related]
31. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
[TBL] [Abstract][Full Text] [Related]
32. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.
Knific T; Vouk K; Smrkolj Š; Prehn C; Adamski J; Rižner TL
J Steroid Biochem Mol Biol; 2018 Apr; 178():312-321. PubMed ID: 29360580
[TBL] [Abstract][Full Text] [Related]
33. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
34. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer.
Vuento MH; Stenman UH; Pirhonen JP; Mäkinen JI; Laippala PJ; Salmi TA
Gynecol Oncol; 1997 Jan; 64(1):141-6. PubMed ID: 8995563
[TBL] [Abstract][Full Text] [Related]
35. LyGDI is a promising biomarker for ovarian cancer.
Zhen H; Yang S; Wu H; Wang S; Lv J; Ma L; Zhang X
Int J Gynecol Cancer; 2010 Apr; 20(3):316-22. PubMed ID: 20375790
[TBL] [Abstract][Full Text] [Related]
36. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.
Nolen BM; Brand RE; Prosser D; Velikokhatnaya L; Allen PJ; Zeh HJ; Grizzle WE; Huang Y; Lomakin A; Lokshin AE
PLoS One; 2014; 9(4):e94928. PubMed ID: 24747429
[TBL] [Abstract][Full Text] [Related]
37. Proteomic Profiling of Serial Prediagnostic Serum Samples for Early Detection of Colon Cancer in the U.S. Military.
Shao S; Neely BA; Kao TC; Eckhaus J; Bourgeois J; Brooks J; Jones EE; Drake RR; Zhu K
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):711-718. PubMed ID: 28003179
[No Abstract] [Full Text] [Related]
38. Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening.
Pedersen JW; Gentry-Maharaj A; Nøstdal A; Fourkala EO; Dawnay A; Burnell M; Zaikin A; Burchell J; Papadimitriou JT; Clausen H; Jacobs I; Menon U; Wandall HH
Int J Cancer; 2014 May; 134(9):2180-88. PubMed ID: 24122770
[TBL] [Abstract][Full Text] [Related]
39. Fourier-transform infrared spectroscopy coupled with a classification machine for the analysis of blood plasma or serum: a novel diagnostic approach for ovarian cancer.
Gajjar K; Trevisan J; Owens G; Keating PJ; Wood NJ; Stringfellow HF; Martin-Hirsch PL; Martin FL
Analyst; 2013 Jul; 138(14):3917-26. PubMed ID: 23325355
[TBL] [Abstract][Full Text] [Related]
40. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
